Welcome to LookChem.com Sign In|Join Free

CAS

  • or

126629-81-0

Post Buying Request

126629-81-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

126629-81-0 Usage

General Description

3-(4-Bromo-phenyl)-3-oxo-propionic acid methyl ester is a chemical compound with the molecular formula C10H9BrO3. It is a yellow to brown solid, commonly used in organic synthesis and pharmaceutical research. 3-(4-BROMO-PHENYL)-3-OXO-PROPIONIC ACID METHYL ESTER is often utilized as a building block for the synthesis of various pharmaceuticals and agrochemicals. It is a methyl ester derivative of 3-(4-bromo-phenyl)-3-oxo-propionic acid, and its structure consists of a benzene ring substituted with a bromine atom and a propionic acid moiety. This chemical has potential applications in the development of new drugs and agrochemicals due to its unique structure and properties.

Check Digit Verification of cas no

The CAS Registry Mumber 126629-81-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,6,2 and 9 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 126629-81:
(8*1)+(7*2)+(6*6)+(5*6)+(4*2)+(3*9)+(2*8)+(1*1)=140
140 % 10 = 0
So 126629-81-0 is a valid CAS Registry Number.

126629-81-0Relevant articles and documents

Synthesis of enantiopure β-amino amides via a practical reductive amination of the corresponding β-keto amides

Mtat, Dalila,Touati, Ridha,Ben Hassine, Béchir

, p. 6354 - 6358 (2014)

A convenient and efficient reductive amination for the preparation of chiral β-amino amides is developed utilizing microwave heating. A variety of chiral β-keto amides react with ammonium acetate and sodium cyanoborohydride to afford the desired functionalized amines in good yields. This improved procedure takes advantage of microwave heating to significantly accelerate the reaction and offers a convenient and effective method to access some interesting molecules containing primary amine functionalities.

Cu-Catalyzed Synthesis of Benzoxazole with Phenol and Cyclic Oxime

Wang, Zheng-Hai,Wang, Dong-Hui

supporting information, p. 782 - 785 (2022/01/20)

A Cu-catalyzed straightforward synthesis of benzoxazoles from free phenols and cyclic oxime esters is reported. The mild reaction conditions tolerate various electron-withdrawing and electron-donating functional groups on both substrates, affording benzoxazoles in moderate to good yields. With this protocol, large-scale syntheses of Ezutromid and Flunoxaprofe in one or two steps are demonstrated. A catalytic mechanism, which includes Cu-catalyzed amination via inner-sphere electron transfer and consequent annulation, is proposed.

Enantioselective decarboxylative Mannich reaction of β-keto acids withC-alkynylN-BocN,O-acetals: access to chiral β-keto propargylamines

Chen, Li-Jun,Li, Wei,Shen, Bao-Chun,Sun, Zhong-Wen,Xie, Hui-Ding,Zhang, Cong-Cong

supporting information, p. 8607 - 8612 (2021/10/20)

The chiral keto-substituted propargylamines are an essential class of multifunctional compounds in the field of organic and pharmaceutical synthesis and have attracted considerable attention, but the related synthetic approaches remain limited. Therefore, a concise and efficient method for the enantioselective synthesis of β-keto propargylaminesviachiral phosphoric acid-catalyzed asymmetric Mannich reaction between β-keto acids andC-alkynylN-BocN,O-acetals as easily availableC-alkynyl imine precursors has been demonstrated here, affording a broad scope of β-ketoN-Boc-propargylamines in high yields (up to 97%) with generally high enantioselectivities (up to 97?:?3 er).

Lysophosphatidic acid receptor antagonists and preparation method thereof

-

Paragraph 0134-0138; 0334-0335; 0336-0338, (2020/07/29)

The invention belongs to the technical field of medicinal chemistry, and particularly relates to lysophosphatidic acid receptor antagonists and a preparation method thereof. The applicant surprisinglyfinds that compounds provided by the invention have high LPAR1 antagonistic activity and selectivity, low toxicity, good metabolic stability and good drug development prospect, and can be used for preventing or treating diseases or symptoms related to LPAR1. The applicant also accidentally finds that the IC50 value of part of the compounds can be as low as 300 nM or below and even 50 nM or below.Moreover, the compounds disclosed by the invention have better safety, and the CC50 range of the compounds can reach 200 [mu]M or above. In addition, the compounds of the present invention have goodmetabolic stability in humans, rats, and mice, such excellent inhibitory activity being very desirable for their use as LPAR1 inhibitors in the above diseases or disorders. In addition, the preparation method of the compounds is simple, mild in reaction condition, high in product yield and suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 126629-81-0